Coupling factor 6 inhibitor and potentiator and use thereof
CA 2350700 A1 · Owner: Daiichi Asubio Pharma Co. Ltd. · Inventors: Osanai, Tomohiro; Magota, Koji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of determining the presence/absence of coupling factor 6 (CF6) which , is a subunit of a proton-translocating ATPase occurring in mitochondria in , blood and measuring the concentration of the factor in blood by using a CF6 antibody, etc.; and techniques of treating various diseases by clarifying the relationships of the changes in the concentration of the factor in blood production of prostacyclin in association with these changes cPLA2 activity, etc. with the diseases to thereby inhibit or potentiate the factor and diagnosing various diseases based on these findings. A process of efficiently producing CF6 or its fragment by using a vector containing a DNA encoding CF6 or its …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 3, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 3, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.